A Trial of E7777 in Persistent and Recurrent Cutaneous T-Cell Lymphoma

Clinical trial NCT01871727 · COMPLETED

Trial details

NCT number: NCT01871727
Sponsor: Eisai Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Persistent or Recurrent Cutaneous T-Cell Lymphoma

Start date: 2013-05-30
Primary completion: 2021-12-06
Enrollment: 112

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.